- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00727935
Comparison Of The Analgesia Obtained By Infiltration For The Joinings Of Episiotomies (Liropep) (LiRoPep)
Comparison Of The Analgesia Obtained By Infiltration Of Lidocaïne 1% And Ropivacaïne 0,75% Versus Placebo For The Joinings Of Episiotomies Among Parturients Under Epidural Analgesia
Lateral episiotomy is a current care practiced with childbirth room. One of the problems encountered with this surgical act is the residual pain on perineal scar level. Maximal during the first 24 hours, this pain can persist several days or several weeks hampering to variable degrees a normal recovery of autonomy and comfort of life. Some studies have shown the interest of ropivacaine, local anaesthetic with a long action's duration for proctologic surgeries and for the cure of inguinal hernia. A recent study shown the ropivacaine perineal infiltration used prior perineorrhaphy allows an absence of post-partum pain for 24 to 27% of cases and a first analgesics request delayed to ten hours.
Methodology: 165 parturients having an epidural analgesia and an episiotomy were enrolled. The perineal infiltration was randomized according to 3 equal groups (placebo, ropivacaine 0,75%, lidocaine 1%) and realised prior perineorrhaphy. then The parturient were followed during the 24 first hours. This study was designed as double blind and the study conduct was standardized in order to get only variable such as the episiotomy infiltration.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Fase 4
Contatti e Sedi
Luoghi di studio
-
-
Pays-de-la-Loire
-
Angers, Pays-de-la-Loire, Francia, 49933
- Centre Hospitalier Universitaire
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Pre-inclusion criteria :
- Assent of participation in the study signed
- Major parturient (> 18 years) in the course of work in room of childbirth
- Mono-foetal pregnancy
- Presentation at the top
Inclusion Criteria:
- Checking of the criteria of pre-inclusion
- Oral confirmation of the assent of the patient
- ASA 1 or 2
- Childbirth by low way
- Patient having an epidural analgesia
- Patient having an episiotomy
- Counter-indication with the ropivacaïne
Pre-exclusion criteria :
- Absence of signed assent of participation in the study
- Counter indication with the lidocaïne
- General counter-indications suitable for the epidural anaesthesia , independently of the local anaesthetic used
- Counter-indications with the infiltration: patient under anticoagulants, coagulopathy
- Allergy to the lidocaine or the ropivacaine
- Allergy to the one of analgesics per bones used in the assumption of responsibility of routine
- Severe insufficiency hepatic and/or renal and/or ulcerates gastro-duodénal (in the case of anti-inflammatory drug regulation not steroid during the postpartum)
- Minor
- Major protected within the meaning of the law Huriet
- Patient during one time of exclusion following another biomedical study
Exclusion Criteria:
- Absence of oral confirmation of the assent of the patient
- Infection or ignition of the point of puncture
- Analgesia epidural not functional
- Dural breach
- Appearance of ascribable side effects to only the anaesthetic buildings at the time of epidural analgesia
- Median Episiotomy (increased risk of lesions of the sphincter)
- Need for an instrumentation at the time of expulsion
- Haemorrhage of the delivery requiring a blood transfusion and/or general anaesthesia in urgency with surgical operation for haemostasis
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Time between the infiltration of the local anaesthetic and the first analgesics catch per os, which is managed when the level of pain evaluated by EVA is higher than 30 mm
Lasso di tempo: 1 year
|
1 year
|
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
To compare between the 3 groups the mean level of the pain during the first 24 hours following the joining of the episiotomy, measured by EVA
Lasso di tempo: 24 hours
|
24 hours
|
|
To compare between the 3 groups the analgesics overall consumption per os during the first 24 hours following the joining of the episiotomy
Lasso di tempo: 24 hours
|
24 hours
|
|
To compare between the 3 groups the total cost of the analgesics consumption (local anaesthetic employed and analgesics per bone) during the first 24 hours following the joining of the episiotomy
Lasso di tempo: 24 hours
|
24 hours
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Laurent Colbus, MD, Centre Hospitalier Universitaire Angers
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Effetti fisiologici delle droghe
- Meccanismi molecolari dell'azione farmacologica
- Agenti antiaritmici
- Depressori del sistema nervoso centrale
- Agenti del sistema nervoso periferico
- Agenti del sistema sensoriale
- Anestetici
- Modulatori di trasporto a membrana
- Anestetici, Locali
- Bloccanti dei canali del sodio voltaggio-dipendenti
- Bloccanti dei canali del sodio
- Lidocaina
- Ropivacaina
Altri numeri di identificazione dello studio
- CHU P 2006-03
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .